Suppr超能文献

《制剂基础:微针阵列制剂,第 1 部分:介绍与概述》。

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview.

机构信息

International Journal of Pharmaceutical Compounding.

出版信息

Int J Pharm Compd. 2022 Sep-Oct;26(5):400-408.

Abstract

Over the years, numerous approaches have been used to increase drug penetration of the skin. Transdermal drug delivery has potential advantages over other conventional routes of drug delivery, as it can provide a non- invasive and painless alternative to parenteral routes. Also, the pharmacokinetic profiles of drugs can be more uniform with less variability, resulting in improved patient compliance. Classical topical formulations are different from those intended for transdermal drug delivery, as they are generally applied to broken, diseased, or damaged skin, whereas, transdermal drugs are applied to healthy skin. On the negative side, the use of transdermal drug delivery is limited by the restrictions inherent in the lipophilic stratum corneum barrier, which allows a limited number of drug molecules with certain physicochemical properties to be delivered. This article, which represents part 1 of a series of articles on compounding with microneedles, provides an introduction and overview of this topic.

摘要

多年来,人们已经尝试了多种方法来增加药物对皮肤的渗透。与其他传统的药物输送途径相比,经皮药物输送具有潜在的优势,因为它可以为患者提供一种非侵入性和无痛的替代注射途径。此外,药物的药代动力学特征可以更加一致,变异性更小,从而提高患者的依从性。经典的局部制剂与用于经皮药物输送的制剂不同,因为它们通常应用于破损、患病或受损的皮肤,而经皮药物则应用于健康的皮肤。从负面的角度来看,经皮药物输送的使用受到亲脂性角质层屏障固有限制的限制,这使得只有数量有限的具有某些物理化学性质的药物分子可以被输送。本文是关于使用微针进行制剂的一系列文章的第 1 部分,对该主题进行了介绍和概述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验